AstraZeneca Pharma India Limited Share Price and Company Fundamentals



Price
₹8418
Change
-191.000 (-2.219%)
52 week range
7201.15 - 10691

Last traded: Last Friday at 9:59 AM

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names. The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Key Metrics

PE ratio

104.38

PB ratio

26.34

Dividend yield

0.38%

Beta

0.15

Market cap

₹210.45B

Enterprise value

₹206.31B

Company profile

Industry / Sector Drug Manufacturers - Specialty & Generic / Healthcare
Full time employees 600
Website https://www.astrazeneca.in
Mailing address Manyata Embassy Business Park Block N1, 12th Floor Rachenahalli Outer Ring Road Bengaluru 560045 India
Phone / Fax 91 80 6774 8000 / 91 80 6774 8557

Dividends

Dividend yield

0.38%

Dividend amount

₹32.00

Payout ratio

39.82%

5Y Avg. yield

-%

AstraZeneca Pharma India Limited paid ₹32.00 dividend and the ex-dividend date was 18 Jul 2025.The dividend payout ratio is 39.82%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ASTRAZEN dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

Company Executives

As of Mar 2026, following are the company executives and directors listed on AstraZeneca Pharma India Limited.

Name Title Age Total Pay
Ms. Bhavana Agrawal Whole-Time Director & CFO
Mr. Praveen Rao Akkinepally MD & Director
Mr. Pankaj S Jain Legal Head
Ms. Tanya Sanish Company Secretary & Compliance Officer
Ms. Smita Saha Vice President of Human Resources 55
Mr. Ayush Kumar Agarwal Business Unit Head of Biopharmaceutical Business Unit
Mr. Vinay Sharma Business Unit Head - Rare Disease unit
Ms. Amarpreet Kaur Ahuja Country HR Director
Mr. Mr. Srikanth B. S. Site Lead, India Operations

Profitability and management effectiveness

Profit margin

9.23%

Operating margin

6.70%

Return on assets

-

Return on equity

-

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of AstraZeneca Pharma India Limited is 210.45B and its enterprise value is 206.31B. The enterprise value to revenue ratio of ASTRAZEN is 9.47. The enterprise value to EBITDA ratio of ASTRAZEN is 69.30.

The ASTRAZEN's stocks Beta value is 0.15 making it 85% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Frequently Asked Questions

1. What is AstraZeneca Pharma India Limited's Stock Symbol?

AstraZeneca Pharma India Limited trades on NSE under the ticker symbol "ASTRAZEN".

2. What is AstraZeneca Pharma India Limited's stock price today?

One share of ASTRAZEN stock can currently be purchased for approximately ₹8418.

3. How can I contact AstraZeneca Pharma India Limited?

AstraZeneca Pharma India Limited's mailing address is Manyata Embassy Business Park Block N1, 12th Floor Rachenahalli Outer Ring Road Bengaluru 560045 India. The company can be reached via phone at 91 80 6774 8000.

4. What is AstraZeneca Pharma India Limited's official website?

The official website of AstraZeneca Pharma India Limited is https://www.astrazeneca.in.